Lipophilicity Optimization Strategy

Lipophilicity optimization strategy balances membrane permeability against aqueous solubility guiding formulation development. Log P measurement quantitates lipophilicity. Excessive lipophilicity impairs solubility causing bioavailability loss. Insufficient lipophilicity prevents membrane penetration. Structure modification iteratively optimises lipophilicity.

Formulation excipients enhance apparent solubility. Supersaturation strategies exploit kinetic solubility. Regulatory submissions justify lipophilicity selections. Post-approval monitoring confirms bioavailability maintenance. Emerging structure-activity relationship analysis guides optimisation.